New Psychoactive Substances
| ISBN: | 9780190095697 |
| Συγγραφέας: | Kristina Adorjan |
| Ημ/νία έκδοσης: | 10/2026 |
| Μορφή: | Paperback |
| Αριθμός έκδοσης: | 1η έκδοση |
| Διαστάσεις: | 24x16 |
| Σελίδες: | 168 |
59,00€7% έκπτωση
55,00€ (συμπ. ΦΠΑ 6%)
23-28 ημέρες Υπό την προϋπόθεση ύπαρξης αποθέματος στον εκδότη
This book delves into the dynamic and increasingly complex world of New Psychoactive Substances (NPS). Between 2009 and 2023, more than 1,250 distinct NPS were identified worldwide, with a record number reported in 2023 alone. This surge reflects a growing diversity, particularly in the categories of synthetic opioids (notably nitazenes), cannabinoids, and stimulants. The emergence of these substances presents significant challenges for public health, law enforcement, and regulatory frameworks, largely due to their novel chemical structures, limited detectability, and serious health risks, including addiction, mental illness, and overdose.
Drawing on the most recent scientific and clinical evidence, this book offers a comprehensive examination of the pharmacological, medical, social, and legal aspects of NPS, with a focus on practical strategies for prevention, diagnosis, and treatment in the field of addiction medicine.
- Presents a thorough examination of New Psychoactive Substances (NPS), drawing on international data and trends, including over 700 substances identified across 106 countries
- Provides professionals with essential knowledge on the physical and psychological effects of NPS, including acute intoxication, long-term health risks, and treatment challenges
- Combines pharmacological, medical, legal, and social perspectives with practical tools for prevention, diagnosis, and care
Introduction
Kristina Adorjan, Sharon L. Walsh, Thomas G. Schulze
Chapter 1. New psychoactive substances: definition and classification
Katarzyna Kuczynska and Jolanta B. Zawilska
Chapter 2. The Pandemic of NPS in Society: an overview of the Social Context
Elisabeth Prevete, Giuseppe Bersani and Ornella Corazza
Chapter 3. Analytical and Biochemical Evaluation of New Psychoactive Substances
Jürg Gertsch
Chapter 4. Stimulant NPS
Fabrizio Schifano, John Martin Corkery, Valeria Catalani, Stefania Chiappini, Davide Arillotta, Alessandro Vento, Norbert Scherbaum, and Amira Guirguis
Chapter 5. New psychoactive substances. Challenges, consequences and treatment approaches
Synthetic Cannabinoid Receptor Agonists (SCRAs)
Dr. Philippe Pfeifer and Dr. Katharina Elisabeth Grafinger
Chapter 6. New Psychoactive Substances: Hallucinogens
Leila Soravia, Tobias Bracht, Niklaus Denier, Yasmin Schmid, and Felix Müller
Chapter 7. Depressant NPS - Synthetic Opioids
Vinz K. Schmid, Boris B. Quednow, and Saraliane Kroll
Chapter 8. NPS related specialities
Kristiane Siste, Rama Kamal, Alexander Baldacchino, Hussien Elkholy, Roshan Bhad, Hamed Ekhtiari, Christian G. Schütz, and Sophia Achab
Chapter 9. Concluding Remarks
Kristina Adorjan, Sharon L. Walsh, Thomas G. Schulze
Στείλτε μια ερώτηση για το προϊόν
Cutting-Edge Strategies in Drug Delivery and Immunotherapy for Autoimmune Disorders
140,00€ 159,00€
23-28 ημέρες
Drug Metabolism Handbook: Concepts and Applications in Cancer Research, 2nd Edition
